Abstract
1 The clinical efficacy of alprazolam has been evaluated in both anxiety states and depressive disorders. In anxiety neurosis, studies have been conducted vs placebo and/or other benzodiazepine tranquilizers. Reports, to date, with regard to panic/phobia disorders have been limited to open-label studies and a single report from a placebo-controlled study. In depression, both open-label and double-blind studies (vs tricyclic antidepressants) have been published.
Keywords: alprazolam, publication review, anxiety depression
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aden G. C. Alprazolam in clinically anxious patients with depressed mood. J Clin Psychiatry. 1983 Jan;44(1):22–24. [PubMed] [Google Scholar]
- Aden G. C., Thein S. G., Jr Alprazolam compared to diazepam and placebo in the treatment of anxiety. J Clin Psychiatry. 1980 Jul;41(7):245–248. [PubMed] [Google Scholar]
- Botte L., Bienfait J., Dethier J., Even P., Evrard J. L., Fraipont J., Goffin L., Willemse P. Comparaison clinique entre alprazolam et lorazepam. Une étude polycentrique en double insu. Acta Psychiatr Belg. 1981 Nov-Dec;81(6):595–608. [PubMed] [Google Scholar]
- Chouinard G., Annable L., Fontaine R., Solyom L. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology (Berl) 1982;77(3):229–233. doi: 10.1007/BF00464571. [DOI] [PubMed] [Google Scholar]
- Cohn J. B. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. J Clin Psychiatry. 1981 Sep;42(9):347–351. [PubMed] [Google Scholar]
- Davison K., Farquharson R. G., Khan M. C., Majid A. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients. Psychopharmacology (Berl) 1983;80(4):308–310. doi: 10.1007/BF00432110. [DOI] [PubMed] [Google Scholar]
- Feighner J. P., Aden G. C., Fabre L. F., Rickels K., Smith W. T. Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA. 1983 Jun 10;249(22):3057–3064. [PubMed] [Google Scholar]
- Feighner J. P. Open label study of alprazolam in severely depressed inpatients. J Clin Psychiatry. 1983 Sep;44(9):332–334. [PubMed] [Google Scholar]
- Feighner J. P., Robins E., Guze S. B., Woodruff R. A., Jr, Winokur G., Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972 Jan;26(1):57–63. doi: 10.1001/archpsyc.1972.01750190059011. [DOI] [PubMed] [Google Scholar]
- France R. D., Krishnan K. R. Alprazolam for endogenous depression. Am J Psychiatry. 1983 May;140(5):640–641. doi: 10.1176/ajp.140.5.640b. [DOI] [PubMed] [Google Scholar]
- Greiss K. C., Fogari R. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety. J Clin Pharmacol. 1980 Nov-Dec;20(11-12):693–699. doi: 10.1002/j.1552-4604.1980.tb01689.x. [DOI] [PubMed] [Google Scholar]
- Maletzky B. M. Anxiolytic efficacy of alprazolam compared to diazepam and placebo. J Int Med Res. 1980;8(2):139–143. doi: 10.1177/030006058000800207. [DOI] [PubMed] [Google Scholar]
- Pitts W. M., Fann W. E., Sajadi C., Snyder S. Alprazolam in older depressed inpatients. J Clin Psychiatry. 1983 Jun;44(6):213–215. [PubMed] [Google Scholar]
- Rickels K., Csanalosi I., Greisman P., Cohen D., Werblowsky J., Ross H. A., Harris H. A controlled clinical trial of alprazolam for the treatment of anxiety. Am J Psychiatry. 1983 Jan;140(1):82–85. doi: 10.1176/ajp.140.1.82. [DOI] [PubMed] [Google Scholar]
- Rush A. J., Schlesser M. A., Erman M., Fairchild C. Alprazolam in bipolar-I depressions. Pharmacotherapy. 1984 Jan-Feb;4(1):40–42. doi: 10.1002/j.1875-9114.1984.tb03311.x. [DOI] [PubMed] [Google Scholar]
- Schatzberg A. F., Cole J. O. Benzodiazepines in depressive disorders. Arch Gen Psychiatry. 1978 Nov;35(11):1359–1365. doi: 10.1001/archpsyc.1978.01770350085008. [DOI] [PubMed] [Google Scholar]